Na tej stronie
01DVA cena
02Zrzut ekranu
03Wykres
04Podziały akcji
05O nas
06Wyniki
07Wycena i wskaźniki
13Dywidendy
14Zyski
15Pełne podstawowe wskaźniki
16Sprawozdania
17Właściciele instytucjonalni (13F)
18Aktywiści i właściciele 5%+
19Insiderzy spółki
20Posiadanie ETF-ów
21Konsensus
22Równi
25Sygnały transakcyjne
26Moje wskaźniki
DVA DaVita Inc. Common Stock
NYSE · Health Care · Wyświetl na SEC EDGAR ↗ zamknij Paź 6, 2026 10-K/10-Q Sie 4, 2026
$180,40
· % zakresu 52 tyg.
· powyżej minimum
· do maksimum
$101,0052tyg. minimum
$247,4952tyg. maksimum
Kapitalizacja Rynkowa (MRQ)
$11.54B
P/E (TTM)
14.8
EPS (TTM)
$12.15
Przychody (TTM)
$14.01B
Twoje odznaki
Zakres 52 tyg.
$101–$247
Ocena Analityków
BUY
Cena Docelowa
$220
P/E
14.8
ROE
-149.4%
Marża Zysku Netto
6.0%
Twój pasek odznak jest pusty — przypnij metrykę w dowolnym miejscu na tej stronie.
DVA Migawka akcji Cena, kapitalizacja rynkowa, P/E, EPS, ROE, zadłużenie/kapitał własny, zakres 52-tygodniowy
Cena
$180.40
Kapitalizacja Rynkowa (MRQ)
$11.54B
P/E (TTM)
14.8
EPS (TTM)
$12.15
Przychody (TTM)
$14.01B
Stopa dywidendy
0.00%
ROE (TTM)
-149.4%
Zakres 52 tyg.
$101–$247
DVA Wykres ceny akcji Dzienny OHLCV ze wskaźnikami technicznymi — przesuwaj, powiększaj i dostosowuj widok
zakres
kreski
Granularność słupków dostosowuje się do wybranego okresu — najedź kursorem na wykres, aby zobaczyć otwarcia/maksima/minima/zamknięcia dla danego słupka.
Podziały akcji
| Data ex-dywidendy | Podział | Typ |
|---|---|---|
| 9 września 2013 | 2-for-1 | Naprzód |
| 16 czerwca 2004 | 3-for-2 | Naprzód |
| 21 października 1997 | 5-for-3 | Naprzód |
O DaVita Inc. Common Stock Przegląd firmy z Wikipedii
DaVita Inc. (a shortened contraction of "dare vita, meaning "to give life" in the Italian language) is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients (36% of the total of 557,000 patients in the U.S.), and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease (ESRD), which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500.
## History
The company was founded in 1979 as Medical Ambulatory Care, Inc., a subsidiary of National Medical Enterprises, Inc. (now Tenet Healthcare).
In August 1994, 70% of the company was acquired by DLJ Merchant Banking Partners in a leveraged buyout for $75.5 million, including a $10.5 million investment by DLJ. The company then changed its name to Total Renal Care Holdings, Inc. In October 1995, the company became a public company via an initial public offering, raising $107 million. By December 1996, DLJ had made a 386% return on its $10.5 million investment.
On February 27, 1998, the company acquired Renal Treatment Centers for $1.3 billion in stock. The integration went poorly and in July 1999, the CEO and CFO resigned. After tripling in value between 1995 and 1998, by July 1999, the stock price was down 71% year-to-date. In October 1999, Kent J. Thiry, then 43 years old, was named CEO.
In 2000, the company sold its non-U.S. operations. In October 2000, the company was renamed DaVita Inc. In October 2005, the company acquired Gambro Healthcare. In 2012, DaVita acquired Healthcare Partners for $4.42 billion, which was renamed DaVita Medical Group. In June 2019, the division was sold to UnitedHealth Group for $4.3 billion. In 2014, DaVita acquired Colorado Springs Health Partners, with 600 employees and 110,000 patients. In March 2016, it acquired the Everett Clinic Medical Group, a 20-site physicians practice with 315,000 patients in the Seattle area, for $385 million. In May 2017, it acquired WellHealth Quality Care.
In October 2014, the company agreed to pay $350 million to settle claims that it provided illegal kickbacks to doctors. In June 2015, the company agreed to pay $450 million to settle allegations that it unnecessarily disposed of drugs and then billed the U.S. federal government for this waste. In June 2018, a jury awarded the families of 3 of the company's patients $383 million in wrongful death claims after the patients died from cardiac arrest after undergoing treatment at DaVita centers. In October 2018, it agreed to pay $270 million to settle allegations that it violated the False Claims Act by providing inaccurate information that caused Medicare Advantage Plans to receive inflated payments. James Swoben, a whistleblower, received $10 million.
In July 2021, a federal grand jury indicted DaVita and former CEO Kent Thiry on charges of labor market collusion alleging participation in conspiracies with Surgical Care Affiliates to suppress competition for the services of certain senior-level employees. The company and Thiry were acquitted by a jury in April 2022. In October 2021, the Federal Trade Commission imposed limits on the company engaging in more mergers in Utah because of its history of buying up competitors.
In 2024, the Federal Trade Commission began investigating Davita along with Fresenius Medical Care under allegations they use illegal tactics to push smaller companies out of the market. In May 2025, the benefits fund of the United Food and Commercial Workers Local 1776 filed a proposed class-action lawsuit against DaVita and Fresenius Medical Care, a rival dialysis provider, alleging that the two companies illegally conspired to inflate treatment costs.
Źródło: Wikipedia (Angielski), CC BY-SA 4.0 · Zobacz w Wikipedii ↗
sektorHealth Care
branżaHealth Care
pracownicy78 000
krajUS
Wyniki 10-letnie Trendy przychodów, zysku netto, marż i EPS
Przychody$13.64B2016-12-31 → 2025-12-31
EPS$9.842016-12-31 → 2025-12-31
Wolny przepływ pieniężny$1.31B2016-12-31 → 2025-12-31
Marża netto6.0%2018-12-31 → 2025-12-31
Wycena i wskaźniki
Wycena Wskaźniki P/E, P/S, P/B, EV/EBITDA — czy akcje są drogie, czy tanie?
| Wskaźnik | Trend 5-letni | DVA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| P/E (TTM) | 14.8średnia z 5 lat ≈13.0 | ≈13.0 | 23.4 | Niedowartościowany | |
| P/S (TTM) | 0.8średnia z 5 lat ≈0.8 | ≈0.8 | 1.8 | Niedowartościowany | |
| P/B (MRQ) | -15.1średnia z 5 lat ≈24.1 | ≈24.1 | · | · | |
| Cena / FCF (TTM) | 7.2średnia z 5 lat ≈7.2 | ≈7.2 | · | · | |
| Cena / Przepływy pieniężne (TTM) | 5.3średnia z 5 lat ≈4.9 | ≈4.9 | 11.3 | Niedowartościowany | |
| Cena / Wartość księgowa materialna (MRQ) | -11.6 | · | · | · | |
| PEG Ratio (Współczynnik PEG) | ≈1.6 | · | · | · |
Mediana porównawcza jest obliczana na znormalizowanej podstawie dla każdej metryki i może nie zawsze odpowiadać podstawie TTM/MRQ pokazanej dla tej akcji.
Rentowność Marże brutto, operacyjne i netto; ROE, ROA, ROIC
| Wskaźnik | Trend 5-letni | DVA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Marża Operacyjna (TTM) | 15.2%średnia z 5 lat ≈14.3% | ≈14.3% | 9.2% | Najwyższa półka | |
| Marża EBITDA (TTM) | 20.2%średnia z 5 lat ≈20.1% | ≈20.1% | 12.7% | Najwyższa półka | |
| Marża przed opodatkowaniem (TTM) | 10.5%średnia z 5 lat ≈10.6% | ≈10.6% | 4.3% | Najwyższa półka | |
| Marża Zysku Netto (TTM) | 6.0%średnia z 5 lat ≈6.3% | ≈6.3% | 5.1% | Najwyższa półka | |
| ROA (TTM) | 4.8%średnia z 5 lat ≈4.6% | ≈4.6% | 3.7% | Najwyższa półka | |
| ROE (TTM) | -149.4%średnia z 5 lat ≈24.7% | ≈24.7% | 10.5% | Słaby | |
| ROIC | -245.6%średnia z 5 lat ≈325.5% | ≈325.5% | 5.1% | Słaby |
Zdrowie finansowe Dług, płynność, wypłacalność — siła bilansu
| Wskaźnik | Trend 5-letni | DVA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Wskaźnik bieżący (MRQ) | 1.5średnia z 5 lat ≈1.3 | ≈1.3 | 1.5 | Zgodnie z | |
| Wskaźnik Szybkości (MRQ) | 1.1średnia z 5 lat ≈1.0 | ≈1.0 | 1.0 | Zgodnie z |
Rozwój Wzrost przychodów, EPS i zysku netto: r/r, CAGR 3-letni, CAGR 5-letni
| Wskaźnik | Trend 5-letni | DVA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Revenue YoY (Przychody R/R) | 6.5%średnia z 5 lat ≈3.4% | ≈3.4% | · | · | |
| Revenue CAGR 3Y (Przychody CAGR 3L) | 5.5%średnia z 5 lat ≈3.5% | ≈3.5% | · | · | |
| Revenue CAGR 5Y (Przychody CAGR 5L) | 3.4% | · | · | · | |
| EPS YoY | -8.3%średnia z 5 lat ≈14.0% | ≈14.0% | · | · | |
| Net Income YoY (Zysk Netto R/R) | -20.2%średnia z 5 lat ≈4.5% | ≈4.5% | · | · | |
| EPS CAGR 3Y (CAGR z EPS 3 lata) | 18.9%średnia z 5 lat ≈10.3% | ≈10.3% | · | · | |
| EPS CAGR 5Y (CAGR z EPS 5 lat) | 9.3% | · | · | · | |
| Net Income CAGR 3Y (CAGR z zysku netto 3 lata) | 10.0%średnia z 5 lat ≈1.6% | ≈1.6% | · | · | |
| Net Income CAGR 5Y (CAGR z zysku netto 5 lat) | -0.70% | · | · | · |
Efektywność kapitałowa Rotacja aktywów, rotacja zapasów, rotacja należności
| Wskaźnik | Trend 5-letni | DVA | średnia z 5 lat | Mediana porównawcza | Werdykt |
|---|---|---|---|---|---|
| Asset Turnover (Rotacja aktywów) | 0.8średnia z 5 lat ≈0.7 | ≈0.7 | 0.8 | Zgodnie z | |
| Receivables Turnover (Rotacja należności) | 6.0średnia z 5 lat ≈6.0 | ≈6.0 | 10.6 | Słaby | |
| Revenue / Employee (Przychody / pracownika) | ≈$174.9K | · | · | · |
wartość · ≈ średnia z 5 lat · mediana branżowa · werdykt względem mediany
Dywidendy Stopa dywidendy, wskaźnik wypłaty, historia dywidend, 5-letni CAGR
Stopa Dywidendy0.00%
Wskaźnik Wypłaty Dywidendy0.00%
Historia zysków EPS faktyczny vs szacowany, zaskoczenie %, wskaźnik trafień, data następnych wyników
Średnie zaskoczenie
0.05%
Następny raport
Paź 27, 2026
| Okres | Raport | EPS Actual | EPS Szacowany | Niespodzianka |
|---|---|---|---|---|
| 30 czerwca 2026 | Sie 3, 2026 | $4.02 | $3.92 | 2.5% |
| 31 marca 2026 | Maj 11, 2026 | $2.87 | $2.34 | 22.6% |
| 31 grudnia 2025 | $3.40 | $3.19 | 6.7% | |
| 30 września 2025 | $2.04 | $3.25 | -37.3% | |
| 30 czerwca 2025 | $2.95 | $2.83 | 4.2% | |
| 31 marca 2025 | $2.00 | $1.97 | 1.7% |
Pełne podstawowe wskaźniki Wszystkie wskaźniki roczne — rachunek zysków i strat, bilans, przepływy pieniężne
Rachunek zysków i strat
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| SG&A Expense | $1.67B | $1.54B | $1.47B | $1.36B | $1.20B | $1.25B | $1.10B | $1.14B | $1.06B | $1.07B | |
| Operating Expenses | $11.60B | $10.73B | $10.54B | $10.27B | $9.82B | $9.86B | $9.75B | $9.88B | $9.06B | $8.68B | |
| Operating Income | $2.04B | $2.09B | $1.60B | $1.34B | $1.80B | $1.69B | $1.64B | $1.53B | $1.81B | $2.03B | |
| Other Non-op | $-103M | $-70M | $-19M | $-16M | $6M | $17M | $29M | $10M | $18M | $8M | |
| Pretax Income | $1.35B | $1.53B | $1.18B | $966M | $1.52B | $1.32B | $1.20B | $1.05B | $1.40B | $1.62B | |
| Income Tax | $293M | $280M | $220M | $198M | $307M | $314M | $280M | $258M | $324M | $432M | |
| Net Income | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| EPS (Basic) | $10.06 | $11.02 | $7.62 | $6.03 | $9.30 | $6.46 | $5.29 | $0.93 | $3.52 | $4.36 | |
| EPS (Diluted) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 | |
| Shares (Basic) | 74,227,000 | 84,991,000 | 90,790,000 | 92,992,000 | 105,230,000 | 119,797,000 | 153,181,000 | 170,786,000 | 188,625,559 | 201,641,173 | |
| Shares (Diluted) | 75,885,000 | 87,274,000 | 93,182,000 | 95,834,000 | 109,948,000 | 122,623,000 | 153,812,000 | 172,365,000 | 191,348,533 | 204,904,656 | |
| EBITDA | $2.75B | $2.81B | $2.34B | $2.06B | $2.47B | $2.31B | $2.24B | $2.10B | $2.36B | $2.44B |
Bilans
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $676M | $795M | $380M | $244M | $462M | $325M | $1.10B | $323M | $508M | $675M | |
| Short-term Investments | $24M | $51M | $12M | $78M | $22M | $20M | $12M | $3M | $33M | $307M | |
| Receivables | $2.41B | $2.15B | $1.99B | $2.13B | $1.96B | $1.82B | $1.80B | $1.86B | $1.71B | $1.50B | |
| Inventory | $161M | $135M | $143M | $109M | $107M | $112M | $98M | $107M | $182M | $160M | |
| Prepaid Expense | $156M | $123M | $103M | $79M | $73M | $76M | $67M | $112M | $112M | $100M | |
| Other Current Assets | · | · | · | · | · | · | · | · | $112M | $100M | |
| Current Assets | $4.06B | $3.75B | $3.14B | $3.16B | $3.17B | $3.15B | $3.69B | $8.42B | $8.77B | $3.99B | |
| PP&E (Net) | $2.81B | $2.94B | $3.07B | $3.26B | $3.48B | $3.52B | $3.47B | $3.39B | $3.15B | $2.86B | |
| PP&E (Gross) | $9.42B | $9.20B | $8.83B | $8.52B | $8.24B | $8.00B | $7.44B | $6.92B | $6.25B | $5.56B | |
| Accum. Depreciation | $6.60B | $6.26B | $5.76B | $5.27B | $4.76B | $4.48B | $3.97B | $3.52B | $3.10B | $2.70B | |
| Goodwill | $7.55B | $7.38B | $7.11B | $7.08B | $7.05B | $6.92B | $6.79B | $6.84B | $6.61B | $6.02B | |
| Intangibles | $222M | $197M | $203M | $183M | $178M | $167M | $136M | $119M | $114M | $74M | |
| Other Non-current Assets | $247M | $262M | $271M | $316M | $137M | $80M | $116M | $72M | $47M | $34M | |
| Total Assets | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Accounts Payable | $696M | $547M | $515M | $480M | $402M | $434M | $404M | $463M | $509M | $457M | |
| Current Liabilities | $3.14B | $2.97B | $2.64B | $2.62B | $2.40B | $2.48B | $2.37B | $4.89B | $3.07B | $2.71B | |
| Capital Leases | $2.18B | $2.21B | $2.33B | $2.50B | $2.67B | $2.74B | $2.72B | $0 | · | · | |
| Deferred Tax | $757M | $665M | $726M | $783M | $831M | $810M | $578M | $563M | $486M | $531M | |
| Other Non-current Liabilities | $84M | $170M | $183M | $105M | $119M | $150M | $161M | $451M | $365M | $317M | |
| Total Liabilities | $16.32B | $15.19B | $14.15B | $14.70B | $14.75B | $14.09B | $13.81B | $14.08B | $13.08B | $12.93B | |
| Common Stock | $69.0K | $90.0K | $89.0K | $90.0K | $97.0K | $110.0K | $126.0K | $166.0K | $182.0K | $195.0K | |
| Retained Earnings | $-328M | $1.53B | $598M | $174M | $354M | $853M | $1.43B | $2.74B | $3.63B | $3.71B | |
| Treasury Stock | $200M | $1.39B | $0 | · | $0 | $0 | $0 | $0 | $0 | $0 | |
| AOCI | $-123M | $-311M | $-52M | $-69M | $-139M | $-66M | $-47M | $-35M | $13M | $-90M | |
| Stockholders' Equity | $-651M | $121M | $1.06B | $712M | $756M | $1.38B | $2.13B | $3.70B | $4.69B | $4.65B | |
| Liabilities + Equity | $17.48B | $17.29B | $16.89B | $16.93B | $17.12B | $16.99B | $17.31B | $19.11B | $18.97B | $18.76B | |
| Shares Outstanding | 68,549,000 | 90,369,000 | 88,824,000 | 90,411,000 | 97,289,000 | 109,933,000 | 125,843,000 | 166,387,000 | 182,462,000 | 194,554,000 |
Przepływy pieniężne
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $708M | $716M | $736M | $721M | $668M | $617M | $601M | $575M | $544M | $495M | |
| Stock-based Comp | $140M | $103M | $112M | $95M | $102M | $91M | $68M | $73M | $35M | $38M | |
| Deferred Tax | $87M | $-58M | $-39M | $-76M | $60M | $241M | $42M | $274M | $-395M | $52M | |
| Amort. of Intangibles | $7M | $7M | $9M | $11M | $13M | $14M | $14M | $16M | $16M | $15M | |
| Other Non-cash | $205M | $324M | $558M | $263M | $122M | $256M | $551M | $691M | $1.06B | $447M | |
| Operating Cash Flow | $1.89B | $2.02B | $2.06B | $1.56B | $1.93B | $1.98B | $2.07B | $1.77B | $1.91B | $1.97B | |
| CapEx | $576M | $555M | $568M | $603M | $641M | $675M | $767M | $987M | $905M | $829M | |
| Investing Cash Flow | $-655M | $-771M | $-772M | $-630M | $-785M | $-825M | $3.00B | $-1.01B | $-1.36B | $-1.20B | |
| Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Net Debt Issued | $5.61B | $6.62B | $2.47B | $2.39B | $1.62B | $4.05B | $38.53B | $59.93B | $50.99B | $51.99B | |
| Stock Repurchased | $1.31B | $1.39B | $272M | $802M | $1.54B | $1.46B | $2.38B | $1.16B | $803M | $1.10B | |
| Net Stock Activity | $-1.31B | $-1.39B | $-272M | $-802M | $-1.54B | $-1.46B | $-2.38B | $-1.16B | $-803M | $-1.10B | |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · | |
| Financing Cash Flow | $-1.37B | $-817M | $-1.17B | $-1.12B | $-1.08B | $-1.85B | $-4.70B | $-625M | $-766M | $-1.35B | |
| Net Change in Cash | $-122M | $415M | $126M | $-216M | $53M | $-707M | $369M | $137M | $-218M | $-577M | |
| Taxes Paid | $177M | $388M | $268M | · | · | · | · | · | · | · | |
| Free Cash Flow | $1.31B | $1.47B | $1.49B | $961M | $1.29B | $1.30B | $1.31B | $785M | $1.00B | $1.13B |
Rentowność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% | 14.7% | 14.4% | 13.4% | · | · | |
| Net Margin | 5.5% | 7.3% | 5.7% | 4.8% | 8.4% | 6.7% | 7.1% | 1.4% | · | · | |
| Pretax Margin | 9.9% | 11.9% | 9.7% | 8.3% | 13.1% | 11.4% | 10.5% | 9.2% | · | · | |
| EBITDA Margin | 20.2% | 21.9% | 19.3% | 17.8% | 21.2% | 20.0% | 19.7% | 18.4% | · | · | |
| ROA | 4.3% | 5.5% | 4.1% | 3.3% | 5.7% | 4.5% | 4.5% | 0.84% | 3.5% | 4.7% | |
| ROE | -281.8% | 159.1% | 78.2% | 76.4% | 91.5% | 44.0% | 27.8% | 3.8% | 14.2% | 18.5% | |
| ROIC | -245.6% | 1410.5% | 123.4% | 149.4% | 189.8% | 93.3% | 59.0% | 31.1% | 29.7% | 28.3% |
Płynność i wypłacalność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 | 1.3 | 1.6 | 1.7 | 2.9 | 1.5 | |
| Quick Ratio | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 | 0.9 | 1.2 | 0.4 | 0.7 | 1.2 |
Efektywność
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.8 | 0.7 | 0.7 | 0.7 | 0.7 | 0.7 | 0.6 | 0.6 | · | · | |
| Receivables Turnover | 6.0 | 6.2 | 5.9 | 5.7 | 6.1 | 6.4 | 6.2 | 6.4 | · | · |
Na akcję
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-9.50 | $1.50 | $11.89 | $7.88 | $7.77 | $12.59 | $16.95 | $22.26 | $25.70 | $23.89 | |
| Revenue / Share | $179.79 | $146.84 | $130.28 | $121.15 | $105.68 | $94.20 | $74.04 | $66.17 | · | · | |
| Cash Flow / Share | $24.86 | $23.17 | $22.10 | $16.33 | $17.56 | $16.14 | $13.47 | $10.28 | $9.97 | $9.58 | |
| Cash / Share | $9.87 | $9.87 | $4.28 | $2.70 | $4.75 | $2.96 | $8.76 | $1.94 | $2.79 | $4.69 | |
| EPS (TTM) | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 | $6.31 | $5.27 | $0.92 | $3.47 | $4.29 |
Stopy Wzrostu
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 6.5% | 5.6% | 4.6% | -0.08% | 0.59% | · | · | · | · | · | |
| Revenue CAGR 3Y | 5.5% | 3.3% | 1.7% | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 3.4% | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -8.3% | 44.6% | 26.8% | -34.3% | 41.0% | · | · | · | · | · | |
| EPS CAGR 3Y | 18.9% | 6.4% | 5.5% | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 9.3% | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -20.2% | 35.4% | 23.4% | -42.7% | 26.5% | · | · | · | · | · | |
| Net Income CAGR 3Y | 10.0% | -1.5% | -3.7% | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | -0.70% | · | · | · | · | · | · | · | · | · |
Wycena (TTM)
| Wskaźnik | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B | $11.55B | $11.39B | $11.40B | $10.88B | $10.71B | |
| Net Income TTM | $747M | $936M | $692M | $560M | $978M | $774M | $811M | $159M | $664M | $880M | |
| Market Cap | $7.79B | $12.04B | $9.31B | $6.75B | $11.07B | $12.91B | $9.44B | $8.56B | $13.18B | $12.49B | |
| P/E | 11.5 | 13.9 | 14.1 | 12.8 | 12.8 | 18.6 | 14.2 | 55.9 | 20.8 | 15.0 | |
| P/S | 0.6 | 0.9 | 0.8 | 0.6 | 1.0 | 1.1 | 0.8 | 0.8 | 1.2 | 1.2 | |
| P/B | -12.0 | 99.4 | 8.8 | 9.5 | 14.6 | 9.3 | 4.4 | 2.3 | 2.8 | 2.7 | |
| P / Cash Flow | 4.1 | 6.0 | 4.5 | 4.3 | 5.7 | 6.5 | 4.6 | 4.8 | 6.9 | 6.4 | |
| P / FCF | 5.9 | 8.2 | 6.2 | 7.0 | 8.6 | 9.9 | 7.2 | 10.9 | 13.2 | 11.0 | |
| Dividend Yield | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | |
| Earnings Yield | 8.7% | 7.2% | 7.1% | 7.8% | 7.8% | 5.4% | 7.0% | 1.8% | 4.8% | 6.7% | |
| Payout Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | · | · | · | |
| Annual Payout | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | · | · |
Rachunek zysków i strat
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.55B | $3.42B | $3.62B | $3.42B | $3.38B | $3.22B | $3.29B | $3.26B | $3.19B | $3.07B | $3.15B | $3.12B | $3.00B | $2.87B | $2.92B | $2.95B | |
| SG&A Expense | $423M | $422M | $472M | $414M | $413M | $374M | $414M | $394M | $368M | $362M | $401M | $377M | $364M | $332M | $380M | $365M | |
| Operating Expenses | $2.98B | $2.93B | $3.06B | $2.91B | $2.84B | $2.78B | $2.73B | $2.73B | $2.68B | $2.59B | $2.76B | $2.63B | $2.60B | $2.56B | $2.66B | $2.64B | |
| Operating Income | $579M | $482M | $561M | $506M | $538M | $439M | $565M | $535M | $506M | $484M | $390M | $496M | $405M | $312M | $256M | $312M | |
| Other Non-op | $8M | $4M | $-21M | $-41M | $-23M | $-18M | $-13M | $-17M | $-27M | $-13M | $-5M | $-20M | $1M | $4M | $-8M | $-5M | |
| Pretax Income | $435M | $341M | $383M | $309M | $369M | $286M | $414M | $373M | $371M | $372M | $289M | $378M | $295M | $215M | $147M | $207M | |
| Income Tax | $92M | $66M | $77M | $69M | $94M | $54M | $64M | $78M | $72M | $66M | $58M | $69M | $49M | $44M | $34M | $43M | |
| Net Income | $265M | $198M | $234M | $150M | $199M | $163M | $259M | $215M | $223M | $240M | $151M | $247M | $179M | $116M | $68M | $105M | |
| EPS (Basic) | $4.10 | $2.93 | $3.30 | $2.09 | $2.62 | $2.05 | $3.17 | $2.56 | $2.56 | $2.73 | $1.68 | $2.70 | $1.96 | $1.28 | $0.81 | $1.16 | |
| EPS (Diluted) | $4.02 | $2.87 | $3.22 | $2.04 | $2.58 | $2.00 | $3.08 | $2.50 | $2.50 | $2.65 | $1.64 | $2.62 | $1.91 | $1.25 | $0.81 | $1.13 | |
| Shares (Basic) | 64,781,000 | 67,390,000 | · | 72,075,000 | 75,943,000 | 79,368,000 | · | 83,721,000 | 86,899,000 | 87,775,000 | · | 91,322,000 | 90,984,000 | 90,497,000 | · | 91,160,000 | |
| Shares (Diluted) | 66,092,000 | 68,875,000 | · | 73,769,000 | 77,362,000 | 81,275,000 | · | 85,795,000 | 88,950,000 | 90,547,000 | · | 94,041,000 | 93,418,000 | 92,483,000 | · | 93,263,000 | |
| EBITDA | $579M | $660M | · | $506M | $538M | $615M | · | $535M | $506M | $671M | · | $496M | $405M | $490M | · | $312M |
Bilans
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $669M | $644M | $676M | $706M | $708M | $439M | $795M | $1.07B | $416M | $345M | · | $449M | $327M | $317M | · | $368M | |
| Short-term Investments | $20M | $22M | $24M | $31M | $31M | $73M | $51M | $21M | $21M | $11M | · | $12M | $12M | $50M | · | $74M | |
| Receivables | $2.47B | $2.46B | $2.41B | $2.33B | $2.44B | $2.32B | $2.15B | $2.27B | $2.30B | $2.59B | · | $2.02B | $2.01B | $2.06B | · | $2.09B | |
| Inventory | $152M | $142M | $161M | $139M | $146M | $151M | $135M | $129M | $127M | $146M | · | $110M | $110M | $107M | · | $107M | |
| Prepaid Expense | $149M | $160M | $156M | $161M | $110M | $130M | $123M | $97M | $83M | $105M | · | $91M | $90M | $89M | · | $66M | |
| Current Assets | $4.19B | $4.06B | $4.06B | $4.11B | $4.09B | $3.64B | $3.75B | $4.04B | $3.47B | $3.68B | · | $3.14B | $3.00B | $3.04B | · | $3.20B | |
| PP&E (Net) | $2.75B | $2.75B | $2.81B | $2.85B | $2.85B | $2.90B | $2.94B | $2.94B | $2.98B | $3.03B | · | $3.10B | $3.16B | $3.22B | · | $3.24B | |
| PP&E (Gross) | · | · | $9.42B | · | · | · | $9.20B | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | $6.87B | · | $6.60B | · | · | · | $6.26B | · | · | · | · | · | · | · | · | · | |
| Goodwill | $7.59B | $7.58B | $7.55B | $7.54B | $7.47B | $7.42B | $7.38B | $7.23B | $7.20B | $7.23B | $7.11B | $7.09B | $7.11B | $7.09B | $7.08B | $7.02B | |
| Intangibles | $229M | $229M | $222M | $220M | $212M | $205M | $197M | $198M | $191M | $201M | · | $185M | $192M | $187M | · | $180M | |
| Other Non-current Assets | $299M | $267M | $247M | $204M | $193M | $239M | $262M | $219M | $240M | $262M | · | $302M | $314M | $291M | · | $308M | |
| Total Assets | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Accounts Payable | $716M | $691M | $696M | $656M | $594M | $596M | $547M | $488M | $494M | $490M | · | $435M | $428M | $448M | · | $417M | |
| Current Liabilities | $2.86B | $2.87B | $3.14B | $3.02B | $2.93B | $2.91B | $2.97B | $2.94B | $2.99B | $2.58B | · | $2.54B | $2.40B | $2.57B | · | $2.54B | |
| Capital Leases | $2.19B | $2.16B | $2.18B | $2.10B | $2.12B | $2.16B | $2.21B | $2.24B | $2.28B | $2.31B | · | $2.34B | $2.38B | $2.46B | · | $2.56B | |
| Deferred Tax | $826M | $819M | $757M | $742M | $646M | $665M | $665M | $660M | $694M | $720M | · | $754M | $760M | $771M | · | $819M | |
| Other Non-current Liabilities | $99M | $89M | $84M | $172M | $156M | $167M | $170M | $183M | $179M | $180M | · | $185M | $183M | $100M | · | $107M | |
| Total Liabilities | $16.63B | $16.45B | $16.32B | $16.22B | $15.94B | $15.46B | $15.19B | $15.28B | $14.60B | $14.79B | · | $14.10B | $14.33B | $14.31B | · | $14.89B | |
| Common Stock | $69.0K | $69.0K | $69.0K | $91.0K | $91.0K | $91.0K | $90.0K | $90.0K | $90.0K | $90.0K | · | $91.0K | $91.0K | $91.0K | · | $98.0K | |
| Retained Earnings | $81M | $-179M | $-328M | $2.05B | $1.90B | $1.70B | $1.53B | $1.28B | $1.06B | $838M | · | $715M | $469M | $290M | · | $847M | |
| Treasury Stock | $788M | $489M | $200M | $2.90B | $2.49B | $2.04B | $1.39B | $1.02B | $616M | $240M | · | · | · | · | · | $788M | |
| AOCI | $-59M | $-87M | $-123M | $-116M | $-138M | $-227M | $-311M | $-162M | $-195M | $-100M | · | $-69M | $-7M | $-55M | · | $-136M | |
| Stockholders' Equity | $-765M | $-755M | $-651M | $-572M | $-370M | $-267M | $121M | $387M | $633M | $926M | · | $1.20B | $1.02B | $825M | · | $533M | |
| Liabilities + Equity | $17.71B | $17.50B | $17.48B | $17.56B | $17.49B | $17.12B | $17.29B | $17.50B | $17.03B | $17.43B | · | $16.93B | $16.96B | $16.73B | · | $16.96B | |
| Shares Outstanding | 63,955,000 | 69,190,000 | 68,549,000 | 70,977,000 | 74,217,000 | 77,277,000 | 80,536,000 | 82,624,000 | 85,081,000 | 89,822,000 | 88,824,000 | 91,348,000 | 91,271,000 | 90,650,000 | 90,411,000 | 90,104,000 |
Przepływy pieniężne
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $168M | $178M | $180M | $177M | $175M | $176M | $167M | $187M | $176M | $187M | $186M | $188M | $184M | $178M | $183M | $194M | |
| Stock-based Comp | $26M | $28M | $38M | $39M | $33M | $30M | $27M | $27M | $24M | $25M | $30M | $27M | $30M | $25M | $18M | $28M | |
| Deferred Tax | $-1M | $55M | $18M | $79M | $-14M | $4M | $-4M | $-25M | $-25M | $-3M | $-22M | $-2M | $-13M | $-4M | $-40M | $-45M | |
| Other Non-cash | · | $-137M | · | · | · | $-193M | · | · | · | $-583M | · | · | · | $147M | · | · | |
| Operating Cash Flow | $490M | $321M | $541M | $842M | $324M | $180M | $548M | $810M | $799M | $-135M | $485M | $661M | $450M | $463M | $344M | $711M | |
| CapEx | $170M | $102M | $145M | $166M | $121M | $143M | $171M | $139M | $125M | $121M | $159M | $137M | $124M | $148M | $194M | $144M | |
| Investing Cash Flow | $-194M | $-139M | $-163M | $-263M | $-67M | $-162M | $-248M | $-146M | $-162M | $-215M | $-168M | $-140M | $-347M | $-117M | $-213M | $-154M | |
| Debt Issued | $1.51B | $1.26B | $940M | $482M | $3.56B | $633M | $676.0K | $3.35B | $1.99B | $1.29B | $6.0K | $331M | $1.53B | $612M | $687M | $523M | |
| Net Debt Issued | · | $1.26B | · | · | · | $633M | · | · | · | $1.29B | · | · | · | $612M | · | · | |
| Stock Repurchased | $181M | $196M | $274M | $240M | $284M | $510M | $365M | $408M | $362M | $251M | $272M | $0 | $0 | $0 | $0 | $185M | |
| Net Stock Activity | · | $-196M | · | · | · | $-510M | · | · | · | $-251M | · | · | · | $0 | · | · | |
| Financing Cash Flow | $-270M | $-213M | $-415M | $-582M | $4M | $-383M | $-565M | $-8M | $-563M | $319M | $-403M | $-395M | $-97M | $-276M | $-231M | $-445M | |
| Net Change in Cash | $25M | $-31M | $-38M | $-2M | $272M | $-355M | $-279M | $655M | $72M | $-34M | $-80M | $123M | $11M | $72M | $-123M | $106M | |
| Free Cash Flow | · | $219M | · | · | · | $37M | · | · | · | $-256M | · | · | · | $315M | · | · |
Rentowność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | 16.3% | 14.1% | · | 14.8% | 15.9% | 13.6% | · | 16.4% | 15.9% | 15.8% | · | 15.9% | 13.5% | 10.8% | · | 10.6% | |
| Net Margin | 7.5% | 5.8% | · | 4.4% | 5.9% | 5.1% | · | 6.6% | 7.0% | 7.8% | · | 7.9% | 6.0% | 4.0% | · | 3.6% | |
| Pretax Margin | 12.2% | 10.0% | · | 9.0% | 10.9% | 8.9% | · | 11.4% | 11.7% | 12.1% | · | 12.1% | 9.8% | 7.5% | · | 7.0% | |
| EBITDA Margin | 16.3% | 19.3% | · | 14.8% | 15.9% | 19.1% | · | 16.4% | 15.9% | 21.9% | · | 15.9% | 13.5% | 17.1% | · | 10.6% | |
| ROA | 1.5% | 1.1% | · | 0.86% | 1.1% | 0.94% | · | 1.2% | 1.3% | 1.4% | · | 1.5% | 1.1% | 0.68% | · | 0.61% | |
| ROE | -46.8% | -38.6% | · | -162.4% | 151.4% | 49.5% | · | 27.1% | 27.0% | 27.4% | · | 28.5% | 22.0% | 13.8% | · | 12.5% | |
| ROIC | -59.7% | -51.4% | · | -68.8% | -108.5% | -133.3% | · | 109.5% | 64.6% | 43.0% | · | 33.8% | 33.2% | 30.0% | · | 46.5% |
Płynność i wypłacalność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.3 | · | 1.4 | 1.2 | 1.4 | · | 1.2 | 1.2 | 1.2 | · | 1.3 | |
| Quick Ratio | 1.1 | 1.1 | · | 1.0 | 1.1 | 1.0 | · | 1.1 | 0.9 | 1.1 | · | 1.0 | 1.0 | 0.9 | · | 1.0 |
Efektywność
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Receivables Turnover | 1.4 | 1.4 | · | 1.5 | 1.4 | 1.3 | · | 1.5 | 1.5 | 1.3 | · | 1.5 | 1.5 | 1.4 | · | 1.4 |
Na akcję
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $-11.96 | $-10.92 | · | $-8.06 | $-4.98 | $-3.46 | · | $4.68 | $7.44 | $10.31 | · | $13.13 | $11.15 | $9.11 | · | $5.91 | |
| Revenue / Share | $53.77 | $49.59 | · | $46.36 | $43.68 | $39.66 | · | $38.04 | $35.83 | $33.91 | · | $33.19 | $32.12 | $31.06 | · | $31.62 | |
| Cash Flow / Share | · | $4.66 | · | · | · | $2.21 | · | · | · | $-1.49 | · | · | · | $5.00 | · | · | |
| Cash / Share | $10.46 | $9.31 | · | $9.95 | $9.55 | $5.68 | · | $12.96 | $4.90 | $3.84 | · | $4.92 | $3.59 | $3.50 | · | $4.08 | |
| EPS (TTM) | $12.15 | $10.71 | · | $9.70 | $10.16 | $10.08 | · | $9.29 | $9.41 | $8.82 | · | $6.59 | $5.10 | $5.49 | · | $6.85 |
Wycena (TTM)
| Wskaźnik | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $14.01B | $13.84B | · | $13.32B | $13.16B | $12.97B | · | $12.67B | $12.52B | $12.34B | · | $11.91B | $11.74B | $11.67B | · | $11.64B | |
| Net Income TTM | $847M | $781M | · | $772M | $836M | $860M | · | $828M | $860M | $816M | · | $609M | $468M | $514M | · | $680M | |
| Market Cap | $14.23B | $10.63B | · | $9.43B | $10.57B | $11.82B | · | $13.54B | $11.79B | $12.40B | · | $8.64B | $9.17B | $7.35B | · | $7.46B | |
| P/E | 18.3 | 14.4 | · | 13.7 | 14.0 | 15.2 | · | 17.6 | 14.7 | 15.7 | · | 14.3 | 19.7 | 14.8 | · | 12.1 | |
| P/S | 1.0 | 0.8 | · | 0.7 | 0.8 | 0.9 | · | 1.1 | 0.9 | 1.0 | · | 0.7 | 0.8 | 0.6 | · | 0.6 | |
| P/B | -18.6 | -14.1 | · | -16.5 | -28.6 | -44.3 | · | 35.0 | 18.6 | 13.4 | · | 7.2 | 9.0 | 8.9 | · | 14.0 | |
| P / Cash Flow | · | 33.1 | · | · | · | 65.7 | · | · | · | -92.0 | · | · | · | 15.9 | · | · | |
| Earnings Yield | 5.5% | 7.0% | · | 7.3% | 7.1% | 6.6% | · | 5.7% | 6.8% | 6.4% | · | 7.0% | 5.1% | 6.8% | · | 8.3% |
Najnowszy okres po lewej · wartości null pokazane jako ·
Sprawozdania finansowe Rachunek zysków i strat, bilans, przepływy pieniężne — roczne, ostatnie 5 lat
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Przychody | $13.64B | $12.82B | $12.14B | $11.61B | $11.62B |
| Marża Operacyjna % | 15.0% | 16.3% | 13.2% | 11.5% | 15.5% |
| Zysk netto | $747M | $936M | $692M | $560M | $978M |
| Rozwodniony EPS | $9.84 | $10.73 | $7.42 | $5.85 | $8.90 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wskaźnik bieżący | 1.3 | 1.3 | 1.2 | 1.2 | 1.3 |
| Wskaźnik Szybkości | 1.0 | 1.0 | 0.9 | 0.9 | 1.0 |
| Wskaźnik | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Wolny przepływ pieniężny | $1.31B | $1.47B | $1.49B | $961M | $1.29B |
Właściciele instytucjonalni (13F) 692 emitenci · $13.6B łącznie · Na dzień 30 września 2026
Instytucje, które zgłaszają posiadanie tych akcji w swoich kwartalnych zgłoszeniach SEC Form 13F. Tylko pozycje długie; pojedynczy zgłaszający może pojawić się dwukrotnie dla oddzielnych transz opcji. Duże przeciwstawne pozycje put/call zazwyczaj odzwierciedlają działalność market-makingową lub zabezpieczone zapasy, a nie przekonanie kierunkowe.
Posiadacze
692
Wartość posiadanych akcji
$13.6B
Nowe pozycje
126
Zamknięte pozycje
61
Aktywność instytucjonalna — Q2 2026 vs poprzedni kwartał
| Nowe pozycje | Zamknięte pozycje | Zwiększone | Zmniejszony | Zmiana liczby akcji netto |
|---|---|---|---|---|
| 126 (-14 vs poprzedni kw.) | 61 (-2 vs poprzedni kw.) | 195 (+23 vs poprzedni kw.) | 226 (+12 vs poprzedni kw.) | -1.1M |
Porównano z Q1 2026. Zgłoszenia SEC Form 13F są wymagane w ciągu 45 dni od końca kwartału plus krótki bufor dla spóźnionych zgłoszeń — kwartały mieszczące się jeszcze w tym terminie są pomijane na rzecz ostatniej w pełni zgłoszonej pary.
| Instytucja | Wartość | Akcje | % z śledzonych 13F | Typ |
|---|---|---|---|---|
| Berkshire Hathaway Inc | $6 425 268 898 | 28 880 209 | 47,23% | Akcje |
| BlackRock, Inc. | $547 520 494 | 2 460 987 | 4,02% | Akcje |
| VANGUARD GROUP INC | $471 976 159 | 4 154 354 | 3,47% | Akcje |
| VANGUARD CAPITAL MANAGEMENT LLC | $467 525 034 | 2 101 425 | 3,44% | Akcje |
| MORGAN STANLEY | $356 348 822 | 1 601 710 | 2,62% | Akcje |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $306 558 307 | 1 377 914 | 2,25% | Akcje |
| STATE STREET CORP | $294 345 267 | 1 323 019 | 2,16% | Akcje |
| Invesco Ltd. | $269 627 293 | 1 211 917 | 1,98% | Akcje |
| DIMENSIONAL FUND ADVISORS LP | $253 130 449 | 1 137 814 | 1,86% | Akcje |
| NEUBERGER BERMAN GROUP LLC | $205 758 498 | 925 579 | 1,51% | Akcje |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $197 802 963 | 889 082 | 1,45% | Akcje |
| GEODE CAPITAL MANAGEMENT, LLC | $189 562 167 | 853 602 | 1,39% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $163 166 832 | 733 400 | 1,20% | Opcja kupna |
| Gates Capital Management, Inc. | $153 096 497 | 688 136 | 1,13% | Akcje |
| BANK OF AMERICA CORP /DE/ | $145 056 737 | 651 999 | 1,07% | Akcje |
| D. E. Shaw & Co., Inc. | $142 571 191 | 640 827 | 1,05% | Akcje |
| AQR CAPITAL MANAGEMENT LLC | $128 131 338 | 587 758 | 0,94% | Akcje |
| GOLDMAN SACHS GROUP INC | $103 093 004 | 463 381 | 0,76% | Akcje |
| Bank of New York Mellon Corp | $101 127 189 | 454 545 | 0,74% | Akcje |
| NORDEA INVESTMENT MANAGEMENT AB | $87 427 043 | 395 687 | 0,64% | Akcje |
| NORTHERN TRUST CORP | $84 995 593 | 382 037 | 0,62% | Akcje |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $81 331 791 | 365 569 | 0,60% | Akcje |
| NORGES BANK | $76 627 007 | 344 422 | 0,56% | Akcje |
| UBS Group AG | $67 900 673 | 305 199 | 0,50% | Akcje |
| JANE STREET GROUP, LLC | $62 548 028 | 281 140 | 0,46% | Akcje |
| JANE STREET GROUP, LLC | $53 573 184 | 240 800 | 0,39% | Opcja kupna |
| Holocene Advisors, LP | $52 875 709 | 237 665 | 0,39% | Akcje |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $48 100 176 | 216 200 | 0,35% | Opcja sprzedaży |
| ROYAL BANK OF CANADA | $47 787 000 | 214 787 | 0,35% | Akcje |
| DEUTSCHE BANK AG\ | $46 356 378 | 208 362 | 0,34% | Akcje |
| Quantinno Capital Management LP | $45 366 106 | 203 910 | 0,33% | Akcje |
| JPMORGAN CHASE & CO | $44 467 785 | 200 781 | 0,33% | Akcje |
| CITADEL ADVISORS LLC | $44 465 298 | 199 862 | 0,33% | Akcje |
| CITADEL ADVISORS LLC | $44 184 528 | 198 600 | 0,32% | Opcja kupna |
| BARCLAYS PLC | $43 410 740 | 195 122 | 0,32% | Akcje |
| VANGUARD FIDUCIARY TRUST CO | $40 134 502 | 180 396 | 0,30% | Akcje |
| WEDGE CAPITAL MANAGEMENT L L P/NC | $37 089 700 | 241 328 | 0,27% | Akcje |
| Gotham Asset Management, LLC | $36 393 278 | 163 580 | 0,27% | Akcje |
| JANE STREET GROUP, LLC | $35 774 784 | 160 800 | 0,26% | Opcja sprzedaży |
| Doma Perpetual Capital Management LLC | $35 522 937 | 159 668 | 0,26% | Akcje |
| FIRST TRUST ADVISORS LP | $34 161 205 | 153 548 | 0,25% | Akcje |
| TODD ASSET MANAGEMENT LLC | $32 697 663 | 146 969 | 0,24% | Akcje |
| LOS ANGELES CAPITAL MANAGEMENT LLC | $32 011 312 | 143 884 | 0,24% | Akcje |
| Allianz Asset Management GmbH | $30 236 367 | 135 906 | 0,22% | Akcje |
| Toroso Investments, LLC | $29 297 520 | 257 878 | 0,22% | Akcje |
| CANADA PENSION PLAN INVESTMENT BOARD | $26 480 460 | 119 024 | 0,19% | Akcje |
| VICTORY CAPITAL MANAGEMENT INC | $26 377 896 | 118 563 | 0,19% | Akcje |
| Amundi | $25 967 198 | 116 717 | 0,19% | Akcje |
| FMR LLC | $25 475 535 | 114 507 | 0,19% | Akcje |
| Davidson Kempner Capital Management LP | $25 162 043 | 113 098 | 0,18% | Akcje |
Aktywiści i właściciele 5%+ 1 akcja
Inwestorzy, którzy złożyli SEC Schedule 13D — posiadanie beneficjentów powyżej 5% z zamiarem wpływania na emitenta (udziały aktywistów, kampanie zarządu, M&A). Każdy wiersz pokazuje najnowszy znany stan pozycji tego zgłaszającego.
| Zgłaszający | Złożono | Udział | Status | Cel | Zgłoszenie |
|---|---|---|---|---|---|
| Warren E. Buffett, Berkshire Hathaway Inc., National Indemnity Company, GEICO Corporation, Government Employees Insurance Company, Berkshire Hathaway Consolidated Pension Plan Master Trust, BNSF Master Retirement Trust, Scott Fetzer Company Collective Investment Trust, R. Ted Weschler ×13 zgłoszenia | 13 lutego 2025 | 45,00% | Aneks | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Insiderzy spółki 59 insiderów · 31 dyrektorzy generalni · 25 dyrektorzy
| Insider | Rola | Ostatnia aktywność | Posiadane akcje | Kupna 12m | Sprzedaże 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Javier Rodriguez | Chief Executive Officer | 16 czerwca 2026 S | 840 408 | 0 | 2 | $-14 532 097 |
| Dennis Kogod | Pres, HCP & CEO, DVA Int. | 17 maja 2016 S | 18 766 | 0 | 0 | $0 |
| Joel Ackerman | CFO and Treasurer | 7 maja 2026 S | 132 434 | 0 | 1 | $-9 887 579 |
| Luis Borgen | Chief Financial Officer | 22 marca 2012 M | 18 517 | 0 | 0 | $0 |
| Richard K Whitney | Chief Financial Officer | 31 marca 2010 A | 33 604 | 0 | 0 | $0 |
| Mark G Harrison | Chief Financial Officer | 14 marca 2007 A | 31 250 | 0 | 0 | $0 |
| Gary Beil | Acting Chief Financial Officer | 1 lipca 2006 A | 10 000 | 0 | 0 | $0 |
| David Paul Maughan | Chief Operating Officer, DKC | 22 września 2026 F | 86 604 | 0 | 2 | $-4 089 696 |
| Michael David Staffieri | Chief Operating Officer, DKC | 16 sierpnia 2024 S | 209 365 | 0 | 0 | $0 |
| Joseph C Mello | COO, HCP | 24 grudnia 2016 A | 4 688 | 0 | 0 | $0 |
| Kathleen Alyce Waters | Chief Legal & Pub. Affairs Off | 15 czerwca 2026 S | 109 194 | 0 | 2 | $-3 210 360 |
| James O Hearty | Chief Compliance Officer | 14 maja 2026 M | 22 389 | 0 | 2 | $-3 291 616 |
| Christopher Michael Berry | Chief Accounting Officer | 15 marca 2026 A | 19 640 | 0 | 0 | $0 |
| John D Winstel | Chief Accounting Officer | 15 marca 2023 F | 15 676 | 0 | 0 | $0 |
| Leanne M Zumwalt | Group VP, Government Affairs | 18 września 2020 M | 24 590 | 0 | 0 | $0 |
| Kent J Thiry | Executive Chairman | 1 czerwca 2020 F | 110 462 | 0 | 0 | $0 |
| James K Hilger | Chief Accounting Officer | 2 czerwca 2019 F | 33 125 | 0 | 0 | $0 |
| Jeanine Marie Jiganti | Chief Compliance Officer | 13 czerwca 2017 M | 3 514 | 0 | 0 | $0 |
| Kim M Rivera | Chief Legal Officer | 22 września 2015 M | 7 438 | 0 | 0 | $0 |
| Robert J Margolis | Co-Chairman of the Board | 4 czerwca 2015 S | 2 322 928 | 0 | 0 | $0 |
| Allen Nissenson | Chief Medical Officer | 13 lutego 2014 M | 8 990 | 0 | 0 | $0 |
| Garry E Menzel | Senior Vice President, Finance | 9 września 2013 A | · | 0 | 0 | $0 |
| David T Shapiro | Chief Special Counsel | 2 sierpnia 2013 G | 2 315 | 0 | 0 | $0 |
| Thomas O Usilton | Senior Vice President | 29 lutego 2012 M | 17 491 | 0 | 0 | $0 |
| Georgina Randolph | Senior Vice President | 17 czerwca 2009 M | 5 547 | 0 | 0 | $0 |
| Joseph Schohl | VP, Gen. Counsel & Secretary | 13 lutego 2009 M | 2 084 | 0 | 0 | $0 |
| Christopher J Riopelle | Chief Compliance Officer | 11 sierpnia 2008 M | 2 500 | 0 | 0 | $0 |
| Mary Kowenhoven | Vice President - Strategy | 5 marca 2008 A | · | 0 | 0 | $0 |
| Patricia Jones | Chief People Officer | 16 lipca 2007 A | 6 250 | 0 | 0 | $0 |
| Charles J Mcallister | Chief Medical Officer | 8 maja 2007 M | 999 | 0 | 0 | $0 |
| Thomas L Kelly | Executive Vice President | 4 listopada 2005 M | 42 000 | 0 | 0 | $0 |
| Dennis W Pullin | Dyrektor | 15 sierpnia 2026 A | 2 949 | 0 | 0 | $0 |
| Gregory J. Moore | Dyrektor | 15 sierpnia 2026 A | 8 091 | 0 | 0 | $0 |
| Jason M. Hollar | Dyrektor | 15 sierpnia 2026 A | 6 883 | 0 | 0 | $0 |
| Patricia M Arway | Dyrektor | 15 sierpnia 2026 A | 27 223 | 0 | 0 | $0 |
| Adam H Schechter | Dyrektor | 15 sierpnia 2026 A | 5 970 | 0 | 0 | $0 |
| Wendy Lee Schoppert | Dyrektor | 15 sierpnia 2026 A | 278 | 0 | 0 | $0 |
| Phyllis R Yale | Dyrektor | 15 sierpnia 2026 A | 9 803 | 0 | 0 | $0 |
| Barbara J Desoer | Dyrektor | 15 sierpnia 2026 A | 278 | 0 | 0 | $0 |
| Charles Berg | Dyrektor | 15 maja 2025 A | 19 982 | 0 | 0 | $0 |
| John M Nehra | Dyrektor | 15 maja 2024 A | 363 | 0 | 0 | $0 |
| Paul J Diaz | Dyrektor | 15 maja 2023 A | 16 069 | 0 | 0 | $0 |
| Paula A Price | Dyrektor | 15 maja 2022 A | 1 395 | 0 | 0 | $0 |
| Shawn M Guertin | Dyrektor | 15 maja 2021 A | 1 105 | 0 | 0 | $0 |
| Pascal Desroches | Dyrektor | 15 listopada 2020 A | 8 030 | 0 | 0 | $0 |
| William L Roper | Dyrektor | 11 czerwca 2020 A | 16 234 | 0 | 0 | $0 |
| Peter T Grauer | Dyrektor | 11 czerwca 2020 A | 76 204 | 0 | 0 | $0 |
| Carol Anthony Davidson | Dyrektor | 31 grudnia 2017 A | 10 764 | 0 | 0 | $0 |
| Willard Woodson Brittain JR | Dyrektor | 11 czerwca 2012 A | 7 195 | 0 | 0 | $0 |
| Richard C Vaughan | Dyrektor | 13 maja 2010 A | 6 092 | 0 | 0 | $0 |
| Nancy Ann Deparle | Dyrektor | 30 czerwca 2008 A | 3 256 | 0 | 0 | $0 |
| Raymond C Larkin JR | Dyrektor | 31 marca 2007 A | 8 684 | 0 | 0 | $0 |
| Michele J Hooper | Dyrektor | 13 maja 2005 A | 680 | 0 | 0 | $0 |
| R. Ted Weschler | · | 17 września 2020 S | 1 991 806 | 0 | 0 | $0 |
| Roger Valine | · | 30 czerwca 2017 A | 306 | 0 | 0 | $0 |
| Laura Mildenberger | · | 17 grudnia 2015 M | 8 447 | 0 | 0 | $0 |
| Richard B Fontaine | · | 16 maja 2007 G | 10 000 | 0 | 0 | $0 |
| Lori Richardson Pelliccioni | · | 25 lutego 2005 M | 3 000 | 0 | 0 | $0 |
| Patrick A Broderick | · | 5 maja 2004 M | 0 | 0 | 0 | $0 |
Insiderzy z zgłoszeń SEC Form 3/4/5; netto = tylko otwarty rynek P/S
Posiadanie ETF-ów Posiadane przez 97 funduszy ETF
Waga odzwierciedla wyłącznie bezpośrednie udziały kapitałowe (N-PORT); fundusze oparte na dźwigni lub instrumentach pochodnych mogą posiadać dodatkowe ekspozycje na swapy, które nie są pokazane.
| Fundusz | Waga | Jednostki | Na dzień | Źródło |
|---|---|---|---|---|
| OMAH · Tidal Trust III | 5,19% | 213 947 NS | 31 lipca 2026 | N-PORT |
| STNC · Hennessy Funds Trust | 3,36% | 13 006 NS | 31 lipca 2026 | N-PORT |
| AZTD · Tidal Trust I | 3,06% | 4 824 NS | 31 lipca 2026 | N-PORT |
| FXH · First Trust Exchange-Traded AlphaDE… | 2,44% | 106 663 NS | 31 lipca 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,61% | 78 824 SH | 5 października 2026 | Dziennie |
| AMOM · Exchange Listed Funds Trust | 1,41% | 1 399 NS | 31 lipca 2026 | N-PORT |
| LSEQ · Harbor ETF Trust | 1,19% | 760 NS | 31 lipca 2026 | N-PORT |
| IHF · iShares Trust | 0,85% | 61 700 SH | 11 września 2026 | Dziennie |
| JMID · Janus Detroit Street Trust | 0,46% | 456 NS | 31 lipca 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,46% | 8 917 NS | 31 lipca 2026 | N-PORT |
| IQSM · New York Life Investments ETF Trust | 0,34% | 4 688 NS | 31 lipca 2026 | N-PORT |
| JPUS · J.P. Morgan Exchange-Traded Fund Tr… | 0,34% | 6 488 NS | 31 lipca 2026 | N-PORT |
| VFMF · VANGUARD WELLINGTON FUND | 0,31% | 9 914 SH | 19 sierpnia 2026 | Dziennie |
| ROSC · Lattice Strategies Trust | 0,27% | 691 NS | 31 lipca 2026 | N-PORT |
| PKW · Invesco Exchange-Traded Fund Trust | 0,24% | 22 494 SH | 5 października 2026 | Dziennie |
| BKMC · BNY Mellon ETF Trust | 0,22% | 5 948 NS | 31 lipca 2026 | N-PORT |
| DFAS · Dimensional ETF Trust | 0,20% | 126 925 NS | 31 lipca 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,20% | 1 063 098 SH | 5 października 2026 | Dziennie |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,18% | 15 260 NS | 31 lipca 2026 | N-PORT |
| FNK · First Trust Exchange-Traded AlphaDE… | 0,15% | 1 456 NS | 31 lipca 2026 | N-PORT |
| VBR · VANGUARD INDEX FUNDS | 0,15% | 467 367 SH | 19 sierpnia 2026 | Dziennie |
| FHLC · FIDELITY COVINGTON TRUST | 0,12% | 15 871 NS | 31 lipca 2026 | N-PORT |
| ISCG · iShares Trust | 0,12% | 6 102 SH | 11 września 2026 | Dziennie |
| VHT · VANGUARD WORLD FUND | 0,11% | 100 394 SH | 19 sierpnia 2026 | Dziennie |
| ESML · iShares Trust | 0,10% | 16 178 SH | 11 września 2026 | Dziennie |
| IYH · iShares Trust | 0,09% | 18 805 SH | 11 września 2026 | Dziennie |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 4 169 SH | 5 października 2026 | Dziennie |
| VB · VANGUARD INDEX FUNDS | 0,09% | 736 199 SH | 19 sierpnia 2026 | Dziennie |
| CURE · Direxion Shares ETF Trust | 0,09% | 632 NS | 31 lipca 2026 | N-PORT |
| SMMD · iShares Trust | 0,08% | 17 274 SH | 11 września 2026 | Dziennie |
| FNX · First Trust Exchange-Traded AlphaDE… | 0,08% | 4 629 NS | 31 lipca 2026 | N-PORT |
| TILT · FlexShares Trust | 0,08% | 7 288 NS | 31 lipca 2026 | N-PORT |
| IXJ · iShares Trust | 0,07% | 16 934 SH | 11 września 2026 | Dziennie |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,07% | 38 208 SH | 5 października 2026 | Dziennie |
| DFAC · Dimensional ETF Trust | 0,06% | 121 442 NS | 31 lipca 2026 | N-PORT |
| IUS · Invesco Exchange-Traded Self-Indexe… | 0,06% | 3 250 SH | 5 października 2026 | Dziennie |
| DUHP · Dimensional ETF Trust | 0,06% | 29 605 NS | 31 lipca 2026 | N-PORT |
| WSML · iShares Trust | 0,05% | 2 005 SH | 10 września 2026 | Dziennie |
| IWS · iShares Trust | 0,05% | 45 297 SH | 11 września 2026 | Dziennie |
| FAB · First Trust Exchange-Traded AlphaDE… | 0,05% | 322 NS | 31 lipca 2026 | N-PORT |
| IWR · iShares Trust | 0,04% | 131 978 SH | 11 września 2026 | Dziennie |
| DCOR · Dimensional ETF Trust | 0,04% | 5 974 NS | 31 lipca 2026 | N-PORT |
| CATH · Global X Funds | 0,04% | 1 967 NS | 31 lipca 2026 | N-PORT |
| XOEF · iShares Trust | 0,04% | 43 SH | 10 września 2026 | Dziennie |
| PRF · Invesco Exchange-Traded Fund Trust | 0,03% | 15 588 SH | 5 października 2026 | Dziennie |
| SPMO · Invesco Exchange-Traded Fund Trust … | 0,03% | 34 484 SH | 5 października 2026 | Dziennie |
| DFAU · Dimensional ETF Trust | 0,03% | 13 203 NS | 31 lipca 2026 | N-PORT |
| CHRI · Global X Funds | 0,02% | 8 NS | 31 lipca 2026 | N-PORT |
| DFSU · Dimensional ETF Trust | 0,02% | 2 124 NS | 31 lipca 2026 | N-PORT |
| EGLE · Global X Funds | 0,02% | 2 NS | 31 lipca 2026 | N-PORT |
| VOOV · VANGUARD ADMIRAL FUNDS | 0,02% | 7 420 SH | 19 sierpnia 2026 | Dziennie |
| VONV · VANGUARD SCOTTSDALE FUNDS | 0,02% | 18 428 SH | 19 sierpnia 2026 | Dziennie |
| IVE · iShares Trust | 0,02% | 53 283 SH | 11 września 2026 | Dziennie |
| IUSV · iShares Trust | 0,02% | 27 948 SH | 11 września 2026 | Dziennie |
| NEAR · iShares U.S. ETF Trust | 0,02% | 949 000 SH | 9 września 2026 | Dziennie |
| DSI · iShares Trust | 0,02% | 4 810 SH | 11 września 2026 | Dziennie |
| IWD · iShares Trust | 0,01% | 67 699 SH | 11 września 2026 | Dziennie |
| XRMI · Global X Funds | 0,01% | 30 NS | 31 lipca 2026 | N-PORT |
| XYLD · Global X Funds | 0,01% | 1 746 NS | 31 lipca 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,01% | 1 706 NS | 31 lipca 2026 | N-PORT |
| DYNF · BlackRock ETF Trust | 0,01% | 27 844 SH | 11 września 2026 | Dziennie |
| XYLG · Global X Funds | 0,01% | 32 NS | 31 lipca 2026 | N-PORT |
| SPUU · Direxion Shares ETF Trust | 0,01% | 121 NS | 31 lipca 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 9 492 NS | 31 lipca 2026 | N-PORT |
| QDPL · Pacer Funds Trust | 0,01% | 766 NS | 31 lipca 2026 | N-PORT |
| TOPC · iShares Trust | 0,01% | 19 SH | 10 września 2026 | Dziennie |
| XVV · iShares Trust | 0,01% | 377 SH | 10 września 2026 | Dziennie |
| VOO · VANGUARD INDEX FUNDS | 0,01% | 832 243 SH | 19 sierpnia 2026 | Dziennie |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 1 019 458 SH | 19 sierpnia 2026 | Dziennie |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 28 136 SH | 19 sierpnia 2026 | Dziennie |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5 315 SH | 19 sierpnia 2026 | Dziennie |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 2 714 SH | 19 sierpnia 2026 | Dziennie |
| ESGV · VANGUARD WORLD FUND | 0,01% | 7 283 SH | 19 sierpnia 2026 | Dziennie |
| XTR · Global X Funds | 0,01% | 2 NS | 31 lipca 2026 | N-PORT |
| HCMT · Direxion Shares ETF Trust | 0,01% | 225 NS | 31 lipca 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 203 SH | 5 października 2026 | Dziennie |
| IWP · iShares Trust | 0,01% | 9 703 SH | 11 września 2026 | Dziennie |
| SPXL · Direxion Shares ETF Trust | 0,01% | 2 512 NS | 31 lipca 2026 | N-PORT |
| IVV · iShares Trust | 0,01% | 404 382 SH | 11 września 2026 | Dziennie |
| IWB · iShares Trust | 0,01% | 22 249 SH | 11 września 2026 | Dziennie |
| IYY · iShares Trust | 0,01% | 1 374 SH | 10 września 2026 | Dziennie |
| IWV · iShares Trust | 0,01% | 8 841 SH | 10 września 2026 | Dziennie |
| ITOT · iShares Trust | 0,01% | 41 624 SH | 11 września 2026 | Dziennie |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 24 SH | 5 października 2026 | Dziennie |
| XCLR · Global X Funds | 0,01% | 1 NS | 31 lipca 2026 | N-PORT |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 1 542 SH | 2 października 2026 | Dziennie |
| IWF · iShares Trust | 0,00% | 6 443 SH | 2 września 2026 | Dziennie |
| GTO · Invesco Actively Managed Exchange-T… | 0,00% | 7 000 | 30 września 2026 | Dziennie |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,00% | 2 838 SH | 19 sierpnia 2026 | Dziennie |
| VGHY · VANGUARD FIXED INCOME SECURITIES FU… | · | · | 15 lipca 2026 | Dziennie |
| VCRB · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VPLS · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| VGMS · VANGUARD MALVERN FUNDS | · | · | 15 lipca 2026 | Dziennie |
| ISCB · iShares Trust | · | 1 571 SH | 11 września 2026 | Dziennie |
| ISCV · iShares Trust | · | 3 661 SH | 11 września 2026 | Dziennie |
| SMLF · iShares Trust | · | 5 973 SH | 11 września 2026 | Dziennie |
| SMMV · iShares Trust | · | 1 837 SH | 1 września 2026 | Dziennie |
DVA Konsensus analityków Bycze i niedźwiedzie opinie analityków, 12-miesięczny cel cenowy, potencjał wzrostu
ocena · 13 analityków
KUP
Średni cel
$220.00
+22,0%
1 7,7%
Mocne kupno
6 46,2%
Kup
5 38,5%
Trzymaj
1 7,7%
Sprzedaj
0 0,0%
Mocna sprzedaż
12-miesięczny cel cenowy
7 analityków · 2026-10-04Średnia cel $219.86 +21,9%
Teraz
Aktualna cena $180.40
Niski$165.00
Średnia$219.86
Wysoki$270.00
Porównanie z porównywalnymi firmami (podbranża GICS) Kluczowe metryki w porównaniu do konkurentów z sektora
Podstawa R/R, ceny według zamknięcia z ostatniego końca roku obrotowego każdej spółki.
| Ticker | Kapitalizacja Rynkowa | P/E | Przychody r/r | Marża Netto | ROE | Marża brutto |
|---|---|---|---|---|---|---|
| DVA | $7.79B | 11.5 | 6.5% | 5.5% | -281.8% | · |
| DGX | $19.09B | 19.8 | 11.8% | 9.0% | 14.2% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| GH | $13.34B | -30.8 | 32.9% | -42.4% | 205.7% | · |
| LH | $20.62B | 24.0 | 7.2% | 6.3% | 10.3% | 28.8% |
| BTSG | $7.20B | 43.0 | 28.2% | 1.5% | 10.8% | 11.8% |
| HNGE | $0 | -6.0 | 50.6% | -89.9% | -299.8% | 79.7% |
| HIMS | · | 63.7 | 59.0% | 5.5% | 23.3% | 73.8% |
| CHE | · | 23.3 | 4.1% | 10.5% | 24.4% | · |
| RDNT | $5.28B | -285.4 | 11.5% | -0.91% | -1.9% | · |
| CVS | $100.87B | 57.1 | 7.8% | 0.44% | 2.4% | · |
Sygnały transakcyjne Ostatnie sygnały kupna/sprzedaży z ceną wejścia i wskaźnikiem ryzyka/zysku
BLUECHIP_DIP
Zrealizowano stop loss
ryzyko 1
nagroda 2,08
wejście
$179.50
R:R 2,08
BLUECHIP_DIP
Wygasły
ryzyko 1
nagroda 2,08
wejście
$176.69
R:R 2,08
Obecnie brak otwartego sygnału — żadna karta nie jest wypełniona, i to jest uczciwe.
Moje wskaźniki Twoja osobista lista obserwowanych — wybrane wiersze z Pełnych Fundamentów
Wybierz wskaźniki, które są dla Ciebie ważne — kliknij + obok dowolnego wiersza w sekcji Pełne dane fundamentalne powyżej.
Twój wybór został zapisany i będzie Ci towarzyszył we wszystkich tickerach.
Źródło: SEC 10-Q złożone Sie 4, 2026